High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$4.7M
$4,660,773
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
OLMA
M
Olema Pharmaceuticals, Inc.
Myles David C.
• Officer • CH. DISCOV. & NON-CLIN DEV OFF
Other
2026-01-14
$243,500
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • CH. DISCOV. & NON-CLIN DEV OFF
Other
|
2026-01-14 | $243,500 | M | Form 4 |
|
OLMA
S
Olema Pharmaceuticals, Inc.
Myles David C.
• Officer • CH. DISCOV. & NON-CLIN DEV OFF
Discretionary Sell
2026-01-14
$1,443,651Largex2
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • CH. DISCOV. & NON-CLIN DEV OFF
Discretionary Sell
|
2026-01-14 | $1,443,651Largex2 | S | Form 4 |
|
OLMA
M
Olema Pharmaceuticals, Inc.
Myles David C.
• Officer • CH. DISCOV. & NON-CLIN DEV OFF
Other
2026-01-13
$243,500
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • CH. DISCOV. & NON-CLIN DEV OFF
Other
|
2026-01-13 | $243,500 | M | Form 4 |
|
OLMA
S
Olema Pharmaceuticals, Inc.
Myles David C.
• Officer • CH. DISCOV. & NON-CLIN DEV OFF
Discretionary Sell
2026-01-13
$1,380,178Largex2
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • CH. DISCOV. & NON-CLIN DEV OFF
Discretionary Sell
|
2026-01-13 | $1,380,178Largex2 | S | Form 4 |
|
OLMA
S
Olema Pharmaceuticals, Inc.
Myles David C.
• Officer • CH. DISCOV. & NON-CLIN DEV OFF
Discretionary Sell
2026-01-12
$283,400
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • CH. DISCOV. & NON-CLIN DEV OFF
Discretionary Sell
|
2026-01-12 | $283,400 | S | Form 4 |
|
OLMA
S
Olema Pharmaceuticals, Inc.
Myles David C.
• Officer • CH. DISCOV. & NON-CLIN DEV OFF
Discretionary Sell
2025-12-19
$1,553,544Largex3
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • CH. DISCOV. & NON-CLIN DEV OFF
Discretionary Sell
|
2025-12-19 | $1,553,544Largex3 | S | Form 4 |